The Future of Meat? Gene-Edited Fungus Offers a Protein-Packed, Sustainable, and Meat-Like Alternative

According to EUREK ALERT!

I. A Protein Revolution Driven by CRISPR Technology 🧬

The global demand for sustainable, high-quality protein is skyrocketing as the environmental costs of traditional animal agriculture become increasingly untenable. A groundbreaking study, published in Cell Press journal Trends in Biotechnology, presents a significant leap forward in this field. Researchers at Jiangnan University in Wuxi, China, have successfully used the gene-editing technology CRISPR-Cas9 to enhance a naturally occurring fungus, creating a super-protein source that is nutritious, eco-friendly, and remarkably meat-like in taste and texture.

The study, led by corresponding author Xiao Liu, focused on the fungus Fusarium venenatum. This organism is already known and approved in many countries (including the UK, US, and China) for its natural meat-like texture and flavor—famous as the organism behind mycoprotein products like Quorn.

However, its natural form has limitations:

• thick, hard-to-digest cell walls, and
• an energy-intensive production process requiring high amounts of sugar and nutrients

II. The “FCPD” Strain: Enhanced for Humans and the Planet

The research team’s innovation was to use CRISPR to precisely edit the fungus’s genome without introducing any foreign DNA, aligning with many global non-GMO regulatory frameworks.

The team removed two targeted genes:

Chitin Synthase Gene

Responsible for building chitin in the fungal cell wall.
Removing it:
→ thinned the cell wall
→ improved digestibility
→ increased protein accessibility

Pyruvate Decarboxylase Gene

Part of central carbon metabolism.
Removing it:
→ re-wired metabolic pathways
→ sharply increased efficiency

Result: A new strain named FCPD

Staggering performance improvements:

• 44% less sugar required to produce the same amount of protein
• 88% faster production, drastically shortening fermentation time

III. A Massive Win for Sustainability

The study conducted a full Life Cycle Assessment (LCA) to calculate the environmental footprint of industrial-scale FCPD production—from spores to final protein.

Reduced Greenhouse Gases

Researchers modeled production in six countries with different energy mixes (e.g., renewable-heavy Finland vs. coal-reliant China).
Across all scenarios, FCPD cut production-related greenhouse gas emissions by up to 61%.

Better Than Chicken

Compared with chicken production in China:

• 70% less land use
• 78% lower freshwater pollution risk

This is vital because animal agriculture contributes ~14% of global greenhouse gas emissions and consumes enormous water and land resources.

IV. Viewpoint: A Scalable Solution for Growing Demand

From an objective standpoint, this research marks a pivotal shift for alternative proteins.
Rather than simply finding substitutes, scientists are now engineering biology to optimize protein performance and sustainability.

Lead author Xiaohui Wu emphasizes that while mycoprotein was already considered sustainable, this is among the first studies to fully quantify and reduce the environmental impact of its production.

By creating a fungal strain that is:

• more digestible
• faster to cultivate
• far less resource-intensive
• dramatically lower in emissions

…the research team provides a scalable, scientifically robust solution to meet global protein demand—without the ecological damage of conventional livestock farming.

References

• Cell Press – Trends in Biotechnology, Gene-Edited Mycoprotein Research
• CRISPR-Cas9 Overview
• Fusarium venenatum Profile

According to EUREK ALERT!

Frequently Asked Questions

What types of genetic modifications are being made to fungi for meat alternative production?

Genetic modifications in fungi for food protein production pursue several goals. Protein yield increases: editing metabolic pathway genes to reduce carbon allocation to non-protein compounds (reducing lipid synthesis, polysaccharide production) and increase allocation to protein synthesis pathways. Amino acid optimisation: overexpressing genes in amino acid biosynthesis pathways to increase proportions of limiting amino acids (methionine, lysine). Texture improvement: modifying cell wall composition (chitin-to-glucan ratios) to alter the fibrous texture of mycoprotein in ways that better mimic muscle fibre structure. Allergen reduction: identifying and eliminating specific protein allergens associated with sensitivity reactions in some consumers. Flavour precursor engineering: introducing genes that produce natural flavour compounds that enhance umami or meaty taste characteristics.

Is gene-edited fungal protein the same as ‘GMO’?

The regulatory and definitional answer depends on the type of genetic modification. Traditional GMO involves inserting genes from other organisms (transgenic modification)—for example, inserting a gene from a bacterium into a fungus. CRISPR gene editing (as used in most next-generation fungal protein development) makes targeted edits to the organism’s existing genome without introducing foreign DNA. In the US, FDA takes a tiered approach: if the edit doesn’t introduce novel proteins (pure deletions or small edits), the product may be regulated similarly to conventionally bred organisms. In the EU, the CJEU ruled in 2018 that all gene-edited organisms are GMOs under EU law, requiring full authorisation. Consumer perception surveys show ‘gene edited’ is less negatively viewed than ‘GMO’ in many markets, but regulatory status significantly affects market access.

How does precision fermentation with fungi compare to conventional fungal fermentation like Quorn?

Conventional fungal fermentation (as used for Quorn’s Fusarium venenatum mycoprotein) uses naturally occurring fungal strains grown on sugar-based media—the fungus grows to produce biomass without specific genetic modification. Precision fermentation uses genetically modified host organisms to produce specific target compounds (proteins, fats, flavour molecules) that may not be naturally produced by the host strain or are produced at much higher titres through metabolic engineering. For food applications, precision fermentation fungi might be engineered to express specific dairy proteins (casein, whey) to produce animal-identical proteins without animals, or specific meat-flavour compounds (haem proteins, specific amino acid profiles) that conventional fermentation cannot achieve. The products differ in concept: conventional fermentation produces the fungal biomass as food; precision fermentation uses the fungus as a factory for specific target molecules.

What is the environmental footprint of gene-edited fungal protein production?

Gene-edited fungal protein production inherits the environmental advantages of conventional fungal fermentation: dramatically lower land use, water consumption, and greenhouse gas emissions than animal agriculture. Gene editing itself adds no significant environmental impact. Precision fermentation using engineered fungi to produce specific proteins may have higher energy costs than conventional fermentation (more precisely controlled fermentation conditions, downstream processing for specific protein isolation) but still achieves substantially better environmental performance than equivalent animal-derived proteins. Life cycle analyses comparing precision fermentation dairy proteins to conventional dairy production show 70–90% reductions in greenhouse gas emissions, land use, and water consumption. The main environmental variable is the energy source for fermentation: renewable energy-powered facilities achieve near-zero carbon production.

Which companies are closest to market with gene-edited fungal proteins?

Several companies are advancing gene-edited or precision fermentation fungal protein products toward commercial scale. Nature’s Fynd (US, backed by Al Gore’s Generation Investment and other major VCs) has received FDA Generally Recognized as Safe (GRAS) acceptance for its Fy protein from Fusarium flavolapis and launched consumer products. Meati Foods (US) uses Neurospora crassa mycelium and is available in US retail. Perfect Day (US) uses precision fermentation with Trichoderma reesei to produce whey protein and has achieved full-scale commercial production of dairy protein ingredients used in branded consumer products. New Wave Foods and other emerging companies are applying similar approaches to seafood alternatives. The FDA’s New Dietary Ingredient and GRAS pathways are being actively used by these companies to achieve regulatory clearance in the US market.